- Home
- Featured Publications
- Center Publications
- SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential.
SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential.
Citation | “Sars-Cov-2-Specific T Cells Exhibit Phenotypic Features Of Helper Function, Lack Of Terminal Differentiation, And High Proliferation Potential.”. Cell Reports. Medicine, p. 100081. . |
Author | Jason Neidleman, Xiaoyu Luo, Julie Frouard, Guorui Xie, Gurjot Gill, Ellen S Stein, Matthew McGregor, Tongcui Ma, Ashley F George, Astrid Kosters, Warner C Greene, Joshua Vasquez, Eliver Ghosn, Sulggi Lee, Nadia R Roan |
Keywords | CD127, COVID-19, CyTOF, IL7, SARS-CoV-2, T cells, convalescent individuals, homeostatic proliferation, mild COVID-19 |
Abstract |
Convalescing coronavirus disease 2019 (COVID-19) patients mount robust T cell responses against SARS-CoV-2, suggesting an important role of T cells in viral clearance. To date, the phenotypes of SARS-CoV-2-specific T cells remain poorly defined. Using 38-parameter CyTOF, we phenotyped longitudinal specimens of SARS-CoV-2-specific CD4+ and CD8+ T cells from nine individuals who recovered from mild COVID-19. SARS-CoV-2-specific CD4+ T cells were exclusively Th1 cells and predominantly Tcm cells with phenotypic features of robust helper function. SARS-CoV-2-specific CD8+ T cells were predominantly Temra cells in a state of less terminal differentiation than most Temra cells. Subsets of SARS-CoV-2-specific T cells express CD127, can proliferate homeostatically, and can persist for over 2 months. Our results suggest that long-lived and robust T cell immunity is generated following natural SARS-CoV-2 infection and support an important role of SARS-CoV-2-specific T cells in host control of COVID-19. |
Year of Publication |
2020
|
Journal |
Cell reports. Medicine
|
Volume |
1
|
Issue |
6
|
Number of Pages |
100081
|
Date Published |
09/2020
|
ISSN Number |
2666-3791
|
DOI |
10.1016/j.xcrm.2020.100081
|
Alternate Journal |
Cell Rep Med
|
PMID |
32839763
|
PMCID |
PMC7437502
|
Download citation |